Charles Schwab Investment Management Inc Nautilus Biotechnology, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 136,354 shares of NAUT stock, worth $319,068. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136,354
Previous 136,354
-0.0%
Holding current value
$319,068
Previous $407,000
1.72%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NAUT
# of Institutions
77Shares Held
63.1MCall Options Held
14KPut Options Held
1.8K-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$38.1 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$29.5 Million0.78% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$16.8 Million0.6% of portfolio
-
Madrona Venture Group, LLC6.02MShares$14.1 Million15.07% of portfolio
-
Black Rock Inc. New York, NY3.73MShares$8.73 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $292M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...